Skip to main navigation Skip to search Skip to main content

Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin

Kelly L. Williams, Emily P. McCann, Jennifer A. Fifita, Katharine Zhang, Emma L. Duncan, Paul J. Leo, Mhairi Marshall, Dominic B. Rowe, Garth A. Nicholson, Ian P. Blair

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Missense and frameshift mutations in TRAF family member-associated NF-kappa-B activator (TANK)-binding kinase 1 (TBK1) have been reported in European sporadic and familial amyotrophic lateral sclerosis (ALS) cohorts. To assess the role of TBK1 in ALS patient cohorts of wider ancestry, we have analyzed whole-exome sequence data from an Australian cohort of familial ALS (FALS) patients and controls. We identified a novel TBK1 deletion (c.1197delC) in a FALS patient of Chinese origin. This frameshift mutation (p.L399fs) likely results in a truncated protein that lacks functional domains required for adapter protein binding, as well as protein activation and structural integrity. No novel or reported TBK1 mutations were identified in FALS patients of European ancestry. This is the first report of a TBK1 mutation in an ALS patient of Asian origin and indicates that sequence variations in TBK1 are a rare cause of FALS in Australia.

    Original languageEnglish
    Pages (from-to)3334.e1-3334.e5
    Number of pages5
    JournalNeurobiology of Aging
    Volume36
    Issue number12
    DOIs
    Publication statusPublished - 1 Dec 2015

    Fingerprint

    Dive into the research topics of 'Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin'. Together they form a unique fingerprint.

    Cite this